April 19: Measles Outbreak Is Going Strong, U.S. Officials Award $350 Million for Opioid Research, and More

Posted on April 19th, 2019 in Industry Updates by Amplicare

The measles outbreak is still going strong, U.S. officials are awarding $350 million for research toward ending the opioid epidemic, patient influencers don’t trust pharma websites for health information, and more industry news from the past week. 

Continue Reading...

Transparency Was A Key Theme at the PBM Senate Hearing

Posted on April 18th, 2019 in Industry Updates by Amplicare

Last week, executives from the five largest PBMs  — CVS Health, Cigna, Prime Therapeutics, Humana, and UnitedHealthcare’s OptumRx — appeared at a Senate Finance Committee hearing to discuss their roles in pharmaceutical supply chain. The high price of prescription drugs has become a rare bipartisan issue.

Continue Reading...

April 12: PBMs Blame Big Pharma for High Drug Prices, Amazon’s Alexa Has New HIPAA-Compliant Skills, and More

Posted on April 12th, 2019 in Industry Updates by Amplicare

PBMs say Big Pharma is responsible for high drug prices, Alexa has new HIPAA-compliant skills, D-SNP look-alike plans may soon be at risk, and more industry news from the past week.

Continue Reading...

Page 1 of 6

Industry Updates

Latest news and updates about the Medicare and pharmacy industries.